For instance, in a spontaneous mouse model of breast cancer (MMTV-PyMT mice), IVM helped to demonstrate that doxorubicin treatment induces recruitment of myeloid cells expressing matrix metalloproteinase 9 (MMP9) into the tumor via the CCL2/CCR2 chemokine/chemokine receptor axis. The gene discussed is MMP9; the disease is breast cancer.